Generics 1


Medical devices



Idelalisib manufacturers

1 products found


1 products found


Tablets 150mg pack of 60

Dossier type
Country of origin
Dossier status
Under Development
GMP approvals
Argentina, PICS

Manufacturer #678

It is situated in the southern part of South America. It is committed to excellence and continuous improvement. They have a production plant for the manufacturing of high value-added products like the treatment of HIV-AIDS and neurodegenerative and cardiovascular diseases.

Manufacturer usually replies in 2 days

Idelalisib is a chemotherapic medication used to treat blood cancers, including chronic lymphocytic leukemia, follicular lymphoma, lymphoma, and non-Hodgkin's lymphoma. In the case of chronic lymphocytic leukemia, it is recommended as a second-line treatment and is typically used alongside rituximab. Suppliers of idelalisib market it as 100mg and 150mg oral tablets. First introduced for medical use in 2014 by developer and earliest idelalisib manufacturer Gilead Sciences, the drug has since become available in over 30 countries worldwide. Given that the patent for the drug is still valid, other producers have yet to join the market with their own generic or trade name formulations of idelalisib. Pharmaceutical specialists are welcome to browse through offers of idelalisib tablets from suppliers on our pharmaceutical marketplace, or else seek out further useful medical information about idelalisib online, at the official Zydelig product website.